Harnessing the Potential of Biosurfactants for Biomedical and Pharmaceutical Applications

Adsorption and wetting properties of biosurfactants, Tritons and their mixtures in aqueous and water-ethanol environment

Adsorption of rhamnolipid (RL) and surfactin (SF) as well as their mixtures with Triton X-100 (TX100) and Triton X-165 (TX165) at the solution-air (S-A), PTFE (polytetrafluoroethylene)-S, PMMA (poly (methyl methacrylate))-S, Q (quartz)-S, PMMA-A, and Q-A as well as their wetting properties regarding the surface tension of the PTFE, PMMA and quartz and its components and parameters were discussed using the literature data. The mutual influence of biosurfactants and Tritons on the S-A, PMMA(quartz)-A and PTFE(PMMA, quartz)-S interfaces tensions was considered in terms of their adsorption at these interfaces for both aqueous and water-ethanol solutions of the biosurfactant mixtures with Tritons. For this purpose there were used different methods on the basis of which the S-A, PMMA(quartz)-A and PTFE(PMMA, quartz)-S interface tensions can be predicted and/or described in the function of concentration and composition of the mixtures. Changes of these interface tensions as a function of concentration and composition of the mixtures were compared to those affected by individual mixture components. In turn, these changes of the interface tension were considered as regards properties of the biosurfactants, Tritons and ethanol layers adsorbed at the S-A, PMMA(quartz)-A and PTFE(PMMA, quartz)-S interfaces. Based on the changes of the contact angle of the aqueous and water-ethanol solutions of the biosurfactants and Tritons as well as biosurfactants mixtures with Tritons on PMMA and quartz as a function of mixture concentration and composition, the changes of the PMMA and quartz surface tension were analyzed using various approaches to the surface and interface tension. The thermodynamic functions change as a results of RL, SF, TX100, TX165, ET as well as the mixtures of RL and SF with Tritons adsorption at different interfaces were also analyzed based on the literature data. These considerations allow to describe and/or predict changes of the interface tension, contact angle of the mixtures as a function of their composition based on these properties of individual mixture components.

Nature's Marvels: Exploring the Multifaceted Applications of Surfactin and Rhamnolipids

Biosurfactants are fascinating amphiphilic molecules synthesized by living sources, such as bacteria and fungi. Biosurfactants can be lipopeptides, glycolipids, lipopolysaccharides, phospholipids, proteins, and polymeric substances in nature. With their unique surface-active properties, these molecules play a vital role in numerous industrial, environmental, and biomedical applications. They are stable molecules that improve biointerfacial interactions, i.e., alter wettability properties and reduce surface tension, enabling efficient emulsification, foaming, and dispersion. For instance, surfactin (a major lipopeptide) is capable of effectively reducing the surface tension of water from 72.80 ± 0.5 to 24.09 ± 0.11 mN/m and reducing the interfacial tension to as low as 0.056 mN/m (for an oil-water interface). Rhamnolipids (a significant glycolipid) demonstrate remarkable stability across a wide range of temperatures (30 to 100 °C), pH (4-12), and salinity (0 to 9% w/v NaCl). For example, the bioremediation of hydrophobic oil molecules happens through emulsifying and solubilizing, along with improving cell surface hydrophobicity. Furthermore, these biosurfactants have also emerged as nature's elegant entity in the food and pharmaceutical sectors by exhibiting excellent antimicrobial, antioxidant, anti-inflammatory, and antitumor properties. The ongoing pursuit of research and innovation of these magic molecules assures a paradigm shift toward a greener and more sustainable future.

Herbal nanoemulsions in cosmetic science: A comprehensive review of design, preparation, formulation, and characterization

The rapid development of delivery systems for cosmetics has revealed two critical challenges in the field: enhancing the solubility of active ingredients and ensuring the stability of natural materials used in cosmetics. Nanoemulsion technology has emerged as an indispensable solution for addressing these challenges, not only enhancing the stability of cosmetics but also improving the solubility of pharmaceuticals and active ingredients with poor solubility. Nanoemulsion formulations have reinforced stability and amended the bioavailability of hydrophobic drugs. Moreover, nanoemulsion exhibit excellent skin penetration and long-lasting effects, making them particularly appealing to consumers, especially in the cosmetic industry. This article aims to provide an overview of herbal nanoemulsion formulations as cosmetic products, covering formulation, production, and characterization. Herbal nanoemulsions is an effective, stable, and promising option for cosmetic delivery. The nanoemulsions were characterized by their key properties, such as particle size, polydisperse index (PDI), zeta potential, viscosity, stability and others. Techniques like zeta potential measurement, transmission electron microscopy (TEM) and scanning electronmicroscopy (SEM) were used to analyze the surface morphology, whereas stability tests were employed to evaluate nanoemulsion performance. This review also delves into the high-energy and the low-energy methods of manufacturing nanoemulsions. Additionally, we also explore the selection of appropriate surfactants, co-surfactants, and ingredients for creating herbal nanoemulsions with desirable attributes and qualities. Overall, this review consolidates the current knowledge on herbal nanoemulsion formulations for cosmetic preparations, designs, shedding light on their effectiveness, characteristics, and stability. These formulations hold promise in overcoming challenges related to meeting the increasing demand for effective herbal nanoemulsion and high-quality cosmetic products.

Integrated genome and metabolome mining unveiled structure and biosynthesis of novel lipopeptides from a deep-sea Rhodococcus

Microbial biosurfactants have garnered significant interest from industry due to their lower toxicity, biodegradability, activity at lower concentrations and higher resistance compared to synthetic surfactants. The deep-sea Rhodococcus sp. I2R has been identified as a producer of glycolipid biosurfactants, specifically succinoyl trehalolipids, which exhibit antiviral activity. However, genome mining of this bacterium has revealed a still unexplored repertoire of biosurfactants. The microbial genome was found to host five non-ribosomal peptide synthetase (NRPS) gene clusters containing starter condensation domains that direct lipopeptide biosynthesis. Genomics and mass spectrometry (MS)-based metabolomics enabled the linking of two NRPS gene clusters to the corresponding lipopeptide families, leading to the identification of 20 new cyclolipopeptides, designated as rhodoheptins, and 33 new glycolipopeptides, designated as rhodamides. An integrated in silico gene cluster and high-resolution MS/MS data analysis allowed us to elucidate the planar structure, inference of stereochemistry and reconstruction of the biosynthesis of rhodoheptins and rhodamides. Rhodoheptins are cyclic heptapeptides where the N-terminus is bonded to a β-hydroxy fatty acid forming a macrolactone ring with the C-terminal amino acid residue. Rhodamides are linear 14-mer glycolipopeptides with a serine- and alanine-rich peptide backbone, featuring a distinctive pattern of acetylation, glycosylation and succinylation. These molecules exhibited biosurfactant activity in the oil-spreading assay and showed moderate antiproliferative effects against human A375 melanoma cells.

Encapsulation nanoarchitectonics of glabridin with sophorolipid micelles for addressing biofilm hazards via extracellular polymeric substance permeation and srtA gene suppression

BACKGROUND

Biofilm, a common drug-resistant phenotype of Staphylococcus aureus (S. aureus), demonstrates significant drug resistance and recurrence due to its extracellular polymeric substance (EPS) barrier and subsequent bacterial migration. Hence, there is an urgent need for effective solutions to mitigate the hazards posed by biofilms.

RESULT

This study developed a stable, low-toxicity multifunctional nanomicelle, GLA@SOL/EYL, by encapsulating glabridin (GLA) using sophorolipid (SOL) and egg yolk lecithin (EYL). Optimizations were performed for the hydration medium, the ratio of carrier materials to GLA, and EYL additions. GLA@SOL/EYL exhibited a particle size of 122.1 ± 0.8 nm and a surface potential of -66.4 ± 1.7 mV, endowing it with the ability to permeate biofilms EPS effectively. GLA@SOL/EYL encapsulated 98.3 ± 1.2 % of GLA and demonstrated a slow-release effect, significantly enhancing the bioavailability of GLA. The addition of EYL reduced the hemolytic toxicity of GLA@SOL/EYL and improved its encapsulation rate and stability. GLA@SOL/EYL reduced the minimum inhibitory concentration of GLA to 8 μg/mL and extended its inhibitory effect at low concentrations by rapidly disrupting the structural integrity of S. aureus. GLA@SOL/EYL may penetrate biofilms to disperse EPS and remove twice as much biofilm as GLA alone, thereby eliminating 99.99 % of S. aureus within biofilms, compared to 99 % bactericidal efficacy of GLA. Additionally, GLA@SOL/EYL inhibited 63.8 ± 1.8 % of biofilm formation by affecting the expression of the srtA gene, thereby reducing the expression of cell wall-anchoring protein genes. In contrast, the biofilm inhibition rates of GLA and blank micelles were less than 10 %.

CONCLUSION

GLA@SOL/EYL utilizes the nanoparticle effect to penetrate biofilms and deliver antimicrobial GLA. The SOL disperses the biofilm matrix while GLA is released to kill S. aureus, preventing bacterial dissemination and colonization. Thus, GLA@SOL/EYL presents an innovative strategy for effectively eradicating S. aureus biofilms and preventing new hazards in a one-step approach.

An Insightful Overview of Microbial Biosurfactant: A Promising Next-Generation Biomolecule for Sustainable Future

Microbial biosurfactant is an emerging vital biomolecule of the 21st century. They are amphiphilic compounds produced by microorganisms and possess unique properties to reduce surface tension activity. The use of microbial surfactants spans most of the industrial fields due to their biodegradability, less toxicity, being environmentally safe, and being synthesized from renewable sources. These would be highly efficient eco-friendly alternatives to petroleum-derived surfactants that would open up new approaches to research on the production of biosurfactants. In the upcoming era, biobased surfactants will become a dominating multifunctional compound in the world market. Research on biosurfactants ranges from the search for novel microorganisms that can produce new molecules, structural and physiochemical characterization of biosurfactants, and fermentation process for enhanced large-scale productivity and green applications. The main goal of this review is to provide an overview of the recent state of knowledge and trends about microbially derived surfactants, various aspects of biosurfactant production, definition, properties, characteristics, diverse advances, and applications. This would lead a long way in the production of biosurfactants as globally successful biomolecules of the current century.

Bioactive baicalin rhamno-nanocapsules as phytotherapeutic platform for treatment of acute myeloid leukemia

Leukemia, particularly acute myeloid leukemia (AML) is considered a serious health condition with high prevalence among adults. Accordingly, finding new therapeutic modalities for AML is urgently needed. This study aimed to develop a biocompatible nanoformulation for effective oral delivery of the phytomedicine; baicalin (BAC) for AML treatment. Lipid nanocapsules (LNCs) based on bioactive natural components; rhamnolipids (RL) as a biosurfactant and the essential oil linalool (LIN), were prepared using a simple phase-inversion method. The elaborated BAC-LNCs displayed 61.1 nm diameter and 0.2 PDI. Entrapment efficiency exceeded 98 % with slow drug release and high storage-stability over 3 months. Moreover, BAC-LNCs enhanced BAC oral bioavailability by 2.3-fold compared to BAC suspension in rats with higher half-life and mean residence-time. In vitro anticancer studies confirmed the prominent cytotoxicity of BAC-LNCs on the human leukemia monocytes (THP-1). BAC-LNCs exerted higher cellular association, apoptotic capability and antiproliferative activity with DNA synthesis-phase arrest. Finally, a mechanistic study performed through evaluation of various tumor biomarkers revealed that BAC-LNCs downregulated the angiogenic marker, vascular endothelial growth-factor (VEGF) and the anti-apoptotic marker (BCl-2) and upregulated the apoptotic markers (Caspase-3 and BAX). The improved efficacy of BAC bioactive-LNCs substantially recommends their pharmacotherapeutic potential as a promising nanoplatform for AML treatment.

Potential of biosurfactant as green pharmaceutical excipients for coating of microneedles: A mini review

Microneedles, a novel transdermal delivery system, were designed to improve drug delivery and address the challenges typically encountered with traditional injection practices. Discovering new and safe excipients for microneedle coating to replace existing chemical surfactants is advantageous to minimize their side effect on viable tissues. However, some side effects have also been observed for this application. The vast majority of studies suggest that using synthetic surfactants in microneedle formulations may result in skin irritation among other adverse effects. Hence, increasing knowledge about these components and their potential impacts on skin paves the way for finding preventive strategies to improve their application safety and potential efficacy. Biosurfactants, which are naturally produced surface active microbial products, are proposed as an alternative to synthetic surfactants with reduced side effects. The current review sheds light on potential and regulatory aspects of biosurfactants as safe excipients in the coating of microneedles.

Biosurfactant complexed with arginine has antibiofilm activity against methicillin-resistant Staphylococcus aureus

Aim: The present study investigated the antimicrobial effectiveness of a rhamnolipid complexed with arginine (RLMIX_Arg) against planktonic cells and biofilms of methicillin-resistant Staphylococcus aureus (MRSA). Methodology: Susceptibility testing was performed using the Clinical & Laboratory Standards Institute protocol: M07-A10, checkerboard test, biofilm in plates and catheters and flow cytometry were used. Result: RLMIX_Arg has bactericidal and synergistic activity with oxacillin. RLMIX_Arg inhibits the formation of MRSA biofilms on plates at sub-inhibitory concentrations and has antibiofilm action against MRSA in peripheral venous catheters. Catheters impregnated with RLMIX_Arg reduce the formation of MRSA biofilms. Conclusion: RLMIX_Arg exhibits potential for application in preventing infections related to methicillin-resistant S. aureus biofilms.

Does regulation hold the key to optimizing lipopeptide production in Pseudomonas for biotechnology?

Lipopeptides (LPs) produced by Pseudomonas spp. are specialized metabolites with diverse structures and functions, including powerful biosurfactant and antimicrobial properties. Despite their enormous potential in environmental and industrial biotechnology, low yield and high production cost limit their practical use. While genome mining and functional genomics have identified a multitude of LP biosynthetic gene clusters, the regulatory mechanisms underlying their biosynthesis remain poorly understood. We propose that regulation holds the key to unlocking LP production in Pseudomonas for biotechnology. In this review, we summarize the structure and function of Pseudomonas-derived LPs and describe the molecular basis for their biosynthesis and regulation. We examine the global and specific regulator-driven mechanisms controlling LP synthesis including the influence of environmental signals. Understanding LP regulation is key to modulating production of these valuable compounds, both quantitatively and qualitatively, for industrial and environmental biotechnology.

Advancements in biosurfactant production using agro-industrial waste for industrial and environmental applications

The adverse effects of waste generation on the environment and public health have raised global concerns. The utilization of waste as a raw material to develop products with enhanced value has opened up novel prospects for promoting environmental sustainability. Biosurfactants obtained from agro-industrial waste are noteworthy due to their sustainability and environmental friendliness. Microorganisms have been employed to generate biosurfactants as secondary metabolites by making use of waste streams. The utilization of garbage as a substrate significantly reduces the expenses associated with the process. Furthermore, apart from reducing waste and offering alternatives to artificial surfactants, they are extensively employed in bioremediation, food processing, agriculture, and various other industrial pursuits. Bioremediation of heavy metals and other metallic pollutants mitigated through the use of bacteria that produce biosurfactants which has been the more recent research area with the aim of improving its quality and environmental safety. Moreover, the production of biosurfactants utilizing agricultural waste as a raw material aligns with the principles of waste minimization, environmental sustainability, and the circular economy. This review primarily focuses on the production process and various types of biosurfactants obtained from waste biomass and feedstocks. The subsequent discourse entails the production of biosurfactants derived from various waste streams, specifically agro-industrial waste.